Kiromic Biopharma Inc (KRBP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KRBP Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Kiromic Biopharma Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent1.14
Cash & Short-term Investments1.00
Other Current Assets0.66
Prepaid Expense And Other Assets Current1.51
Total Current Assets3.30
Equipment/Property/Plant Net4.31
Other Assets, Noncurrent0.93
Restricted Cash Current0.66
Operating Lease Right Of Use Asset0.91
Total Assets8.55
Liabilities
Accounts Payable, Current AC2.68
Interest Payable, Current IN1.65
Notes Payable, Current NO0.42
Other Liabilities, Current16.17
Total Current Liabilities20.90
Total Long-term Debt0.00
Other liabilities, Noncurrent0.23
OperatingLeaseLiabilityNoncurrent0.23
Accrued Liabilities And Other Liabilities Current2.24
Total Liabilities21.13
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock137.21
Retained Earnings / Accumulated Deficit-149.80
Other Equity0.00
Common Stockholder's Equity-12.59
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-12.59
Liabilities & Stockholder's Equity8.55
4 historic quarters locked

Sign in to unlock the full Kiromic Biopharma Inc balance sheet history.

About Kiromic Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-24-034182

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.